Engineering Mesoscopic 3D Tumor Models with a Self-Organizing Vascularized Matrix.

Area of Science:

• Biomedical Engineering
• Cancer Research
• Tissue Engineering

Background:

• Current in vitro models like spheroids and lab-on-a-chip devices struggle to replicate human disease complexity at the tissue scale.
• Advanced models are needed to study tumor pathophysiology, cellular interactions, and drug responses more accurately.

Purpose of the Study:

• To develop a bioprinted artificial tumor model that self-organizes into functional vascular structures.
• To investigate the interplay between tumor spheroids and engineered vasculature.
• To create a platform for studying cancer cell migration and drug testing.

Main Methods:

• Embedding multicellular tumor spheroids in 3D hydrogel matrices with endothelial and stromal cells.
• Utilizing bioprinting techniques to create perfusable and functional vascular networks.
• Analyzing tumor growth, vascularization, cell migration, and preservation of patient-specific tumor characteristics.

Main Results:

• The bioprinted model successfully formed self-organizing, perfusable vascular structures within mesoscopic tumor spheroids.
• Engineered vascular networks promoted tumor spheroid growth and were infiltrated by cancer cells.
• The model preserved key tumor characteristics like desmoplasia, angiogenesis, and metastatic propensity from patient-derived samples.
• Cancer cells demonstrated spontaneous migration through the vascular network into the fluid flow.

Conclusions:

• The modular bioprinted tumor model offers a more physiologically relevant in vitro system for studying tumor development and interactions.
• This platform facilitates advanced drug testing and reduces reliance on in vivo experimentation.
• The model's ability to mimic patient-specific tumor behaviors opens new avenues for personalized medicine research.